Begun as a single-room laboratory in a Staten Island hospital in 1887, the NIH has ballooned into a $47 billion organization ...

Selumetinib is currently FDA approved for children 2 years and older with symptomatic and inoperable plexiform neurofibromas.

An FDA advisory committee on Wednesday unanimously voted against recommending approval of the PARP inhibitor talazoparib (Talzenna) plus enzalutamide (Xtandi) for all patients with metastatic ...

Dr. Dinarello has trained over 50 medical investigators, many of whom are recognized as experts in their fields of medicine. The Institute for Science Information has listed Dr. Dinarello as the world ...

Minimal residual disease-negativity after treatment in DLBCL strongly correlates with remission and overall survival. However ...

Twenty-seven minutes into a town hall with staff last week, US National Institutes of Health Director Dr. Jay Bhattacharya ...

On day 2 of an FDA advisory meeting to consider a new treatment for non–muscle invasive bladder cancer, an FDA official warns ...

Dozens of staff at the NIH walked out of a recent town hall meeting after Director Dr Jay Bhattacharya suggested the agency may have helped fund research that caused the COVID-19 pandemic.

Long-term results from the Women’s Health Initiative have revealed associations between cancers and hormone therapy, supplements, diet, BMI, metabolic syndrome, and NSAIDs.

Under the Trump administration, the Department of Health and Human Services has canceled or frozen billions of dollars in ...

This is why a cross-disciplinary team led by Huntsman Cancer Institute researchers Manish Kohli, MD, a specialist in prostate cancer ... provides care to the largest geographic region of any National ...

Sagar Patel, MD In the approach being tested in the trial ... The critical research happening every day at Huntsman Cancer Institute is supported by the National Institutes of Health/National Cancer ...